153 related articles for article (PubMed ID: 26456902)
1. Timely disclosure of progress in long-term cancer survival: the boomerang method substantially improved estimates in a comparative study.
Brenner H; Jansen L
J Clin Epidemiol; 2016 Feb; 70():224-32. PubMed ID: 26456902
[TBL] [Abstract][Full Text] [Related]
2. Cancer survival in Germany and the United States at the beginning of the 21st century: an up-to-date comparison by period analysis.
Gondos A; Arndt V; Holleczek B; Stegmaier C; Ziegler H; Brenner H
Int J Cancer; 2007 Jul; 121(2):395-400. PubMed ID: 17372898
[TBL] [Abstract][Full Text] [Related]
3. Expected years of life lost for six potentially preventable cancers in the United States.
Liu PH; Wang JD; Keating NL
Prev Med; 2013 May; 56(5):309-13. PubMed ID: 23428566
[TBL] [Abstract][Full Text] [Related]
4. Cancer net survival on registry data: use of the new unbiased Pohar-Perme estimator and magnitude of the bias with the classical methods.
Roche L; Danieli C; Belot A; Grosclaude P; Bouvier AM; Velten M; Iwaz J; Remontet L; Bossard N
Int J Cancer; 2013 May; 132(10):2359-69. PubMed ID: 22961565
[TBL] [Abstract][Full Text] [Related]
5. Probabilities of dying from cancer and other causes in French cancer patients based on an unbiased estimator of net survival: a study of five common cancers.
Charvat H; Bossard N; Daubisse L; Binder F; Belot A; Remontet L
Cancer Epidemiol; 2013 Dec; 37(6):857-63. PubMed ID: 24063904
[TBL] [Abstract][Full Text] [Related]
6. Leading cancers--changes in five-year relative survival.
Ellison LF; Gibbons L
Health Rep; 2004 Mar; 15(2):19-32. PubMed ID: 15151028
[TBL] [Abstract][Full Text] [Related]
7. Long-term survival rates of cancer patients achieved by the end of the 20th century: a period analysis.
Brenner H
Lancet; 2002 Oct; 360(9340):1131-5. PubMed ID: 12387961
[TBL] [Abstract][Full Text] [Related]
8. Adjusting relative survival estimates for cancer mortality in the general population.
Ellison LF
Health Rep; 2014 Nov; 25(11):3-9. PubMed ID: 25408490
[TBL] [Abstract][Full Text] [Related]
9. Overall and cancer-specific survival of patients with breast, colon, kidney, and lung cancers with and without chronic lymphocytic leukemia: a SEER population-based study.
Solomon BM; Rabe KG; Slager SL; Brewer JD; Cerhan JR; Shanafelt TD
J Clin Oncol; 2013 Mar; 31(7):930-7. PubMed ID: 23341508
[TBL] [Abstract][Full Text] [Related]
10. Five-year relative survival from prostate, breast, colorectal and lung cancer.
Ellison LF; Gibbons L;
Health Rep; 2001 Dec; 13(1):23-34. PubMed ID: 15069806
[TBL] [Abstract][Full Text] [Related]
11. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
12. Variation, precision and validity of 1-year survival estimates for lung, breast, colon and prostate cancer in South East England primary care trusts.
Lake J; Mak V; Møller H; Davies EA
Public Health; 2012 Jan; 126(1):57-63. PubMed ID: 22153886
[TBL] [Abstract][Full Text] [Related]
13. Use of period analysis for providing more up-to-date estimates of long-term survival rates: empirical evaluation among 370,000 cancer patients in Finland.
Brenner H; Söderman B; Hakulinen T
Int J Epidemiol; 2002 Apr; 31(2):456-62. PubMed ID: 11980816
[TBL] [Abstract][Full Text] [Related]
14. Stage at diagnosis and early mortality from cancer in England.
McPhail S; Johnson S; Greenberg D; Peake M; Rous B
Br J Cancer; 2015 Mar; 112 Suppl 1(Suppl 1):S108-15. PubMed ID: 25734389
[TBL] [Abstract][Full Text] [Related]
15. Conditional relative survival of cancer patients and conditional probability of death: a French National Database analysis.
Bouvier AM; Remontet L; Hédelin G; Launoy G; Jooste V; Grosclaude P; Belot A; Lacour B; Estève J; Bossard N; Faivre J;
Cancer; 2009 Oct; 115(19):4616-24. PubMed ID: 19569252
[TBL] [Abstract][Full Text] [Related]
16. Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data.
Verdecchia A; Francisci S; Brenner H; Gatta G; Micheli A; Mangone L; Kunkler I;
Lancet Oncol; 2007 Sep; 8(9):784-96. PubMed ID: 17714993
[TBL] [Abstract][Full Text] [Related]
17. Up-to-date and precise estimates of cancer patient survival: model-based period analysis.
Brenner H; Hakulinen T
Am J Epidemiol; 2006 Oct; 164(7):689-96. PubMed ID: 16840519
[TBL] [Abstract][Full Text] [Related]
18. Aspects of survival from colorectal cancer in Denmark.
Iversen LH
Dan Med J; 2012 Apr; 59(4):B4428. PubMed ID: 22459726
[TBL] [Abstract][Full Text] [Related]
19. Cost of care for elderly cancer patients in the United States.
Yabroff KR; Lamont EB; Mariotto A; Warren JL; Topor M; Meekins A; Brown ML
J Natl Cancer Inst; 2008 May; 100(9):630-41. PubMed ID: 18445825
[TBL] [Abstract][Full Text] [Related]
20. An empirical evaluation of period survival analysis using data from the Canadian Cancer Registry.
Ellison LF
Ann Epidemiol; 2006 Mar; 16(3):191-6. PubMed ID: 16099673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
